Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Morphosys AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

16 May 2015 Reuters Investment Profile 12 $20.00

MorphoSys AG (MOR) - Financial Analysis Review

MorphoSys AG (MOR) - Financial Analysis Review Summary MorphoSys AG (Morphosys) is a biotechnology company. The company...

19 May 2015 GlobalData 44 $125.00

Company Snapshot - Morphosys Ag

A director at Morphosys Ag bought 1,000 shares at 63.510EUR and the significance rating of the trade was 66/100. Is that inf...

18 May 2015 Directors Deals Ltd. 1 $12.00

MORPHOSYS - MOVING BEYOND ANTIBODIES

MorphoSys’s acquisition of Lanthio Pharma adds a promising product due to enter Phase I in 2016 and diversifies its portfolio...

18 May 2015 Edison Investment Research 3 $10.00

Is MorphoSys AG Undervalued?

08 May 2015 Sadif Analytics Prime 12 $25.00

MORG.DE - Event Transcript of Morphosys AG conference call, May 05, 2015 / 8:00AM ET

Edited Event Transcript of MORG.DE conference call, May 05, 2015 / 8:00AM ET Boston, May 11, 2015 (Thomson StreetEvents...

05 May 2015 Thomson Reuters StreetEvents 9 $75.00

Wright Investors Service Comprehensive Report for MorphoSys AG

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

21 Apr 2015 Wright Reports 56 $75.00

MORPHOSYS - BACK TO PLAN A

MorphoSys and Celgene have ended their co-development alliance for MOR202. This has no immediate impact on MOR202's developme...

20 Apr 2015 Edison Investment Research 7 $10.00

MORG.DE - Event Transcript of Morphosys AG conference call, Mar. 27, 2015 / 8:00AM ET

Edited Event Transcript of MORG.DE conference call, Mar. 27, 2015 / 8:00AM ET Boston, Mar 27, 2015 (Thomson StreetEvent...

27 Mar 2015 Thomson Reuters StreetEvents 13 $75.00

MorphoSys AG: Upgraded to Good

16 Mar 2015 Sadif Analytics Prime 3 $10.00